Envestnet Asset Management Inc. Reduces Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)
Envestnet Asset Management Inc. trimmed its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 20.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,455 shares of the biopharmaceutical company’s stock after selling 6,612 shares during the quarter. Envestnet […]
Envestnet Asset Management Inc. trimmed its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 20.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,455 shares of the biopharmaceutical company’s stock after selling 6,612 shares during the quarter. Envestnet […]
